Hildegard M. Schuller, D.V.M., Ph.D. is director of the Experimental Oncology Laboratory and Distinguished Professor of Comparative Pathology, Department of Biomedical & Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee Knoxville, TN, USA. She held positions as Assistant and Associate Professor at the Medical School Hannover (Germany), appointments as group leader at the NCI Frederick Cancer Research Center, Frederick, MD and acting chief, Division of Cancer Treatment, NCI, Bethesda, MD. Dr. Schuller joined the University of Tennessee in 1985. Dr. Schuller’s research focuses on the role of neurotransmitters in the development and progression of lung cancer and pancreatic cancer as targets for cancer intervention. Dr. Schuller is the discoverer of a growth-regulating role of nicotinic acetylcholine receptors for small cell lung cancer and of beta-adrenergic receptors and GABA-B receptors for adenocarcinomas of the lungs and pancreas. Dr. Schuller has published 242 peer-reviewed articles in national and international journals.